Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5652 record(s)

Req # A-2019-002019

Adverse Reaction Report (AER). Report number: 000728386.

Organization: Health Canada

2 page(s)
April 2020

Req # A-2019-002033

Adverse Reaction Report (AER). Report number: E2B_02691252.

Organization: Health Canada

29 page(s)
April 2020

Req # A-2019-002079

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_02647196.

Organization: Health Canada

14 page(s)
April 2020

Req # A-2019-002083

Adverse Reaction Report (AER). Report number: E2B_02699083.

Organization: Health Canada

26 page(s)
April 2020

Req # A-2019-001850

Adverse Reaction Report (AER). Report number: E2B_02781314.

Organization: Health Canada

43 page(s)
March 2020

Req # A-2015-000172

All documentation regarding the establishment of bioequivalence or therapeutic or clinical equivalence of subsequent-entry inhaled respiratory medication.

Organization: Health Canada

459 page(s)
March 2020

Req # A-2018-001153

All Briefing Notes regarding the suspension and potential revocation of Agrima Botanicals Corp (Ascent Industries Corp. subsidiary) from September 1, 2018 to December 31, 2018.

Organization: Health Canada

1 page(s)
March 2020

Req # A-2018-001634

All communications plans or strategies, and consultation plans or strategies, developed to guide communications products or activities directed to the Canadian public related to the coming into force of the Cannabis Act. Timeframe: September 2016 to…

Organization: Health Canada

234 page(s)
March 2020

Req # A-2019-000891

Original request for Natural Product Number (NPN) with product issuance letter and product licence for the following natural health product "Chest Rub Iiii; Chest Rub; Respirafect (R) Chest Rub"; NPN: 80070473; Licence holder: St. Francis…

Organization: Health Canada

85 page(s)
March 2020

Req # A-2019-001048

Complete inspection reports on Attix Corporation for the last three Health Canada inspections.

Organization: Health Canada

117 page(s)
March 2020
Date modified: